Our goal is to optimize asparaginase therapy of acute lymphoblastic leukemia (age 1-45 years) by studying the pharmacokinetics, the pharmacodynamics and toxicities related to the treatment for the improvement of the relapse-free survival and reduction of acute toxicities and late effects.
We support parents who lose a child during pregnancy or childbirth. Our research focuses on mental, emotional, and existential consequences of a perinatal loss and how we can improve care and support for bereaved parents. We use data from the Danish Life after the Loss cohort complemented by qualitative methods.
Our research group study reproductive health and childbirth. We use quantitative and qualitative methods to increase our knowledge. Our goal is to ensure the appropriate balance between health promotion, prevention, and treatment to gain optimal public health and maintaining autonomy for the individual.